Search over 3,000 reports

    Keytruda- Drug Insights, 2017

    Keytruda- Drug Insights, 2017
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0130
    DelveInsight's pharmaceuticals report, " Keytruda Drug Insights, 2017" highlights the Drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Keytruda covering the historical global sales and also provides the Keytruda sales estimation during the forecasted period (2017-2019). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Keytruda and emerging therapies in this space.


    A review of the Keytruda, based on information derived from company and industry-specific sources
    Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
    Coverage of the Drug Master Files and API Manufacturers by country
    Patent Expiry Timeline and Exclusivity Details
    Route of Synthesis of the API
    Forecasted Sales Figure from 2017-2019
    Market competition and emerging therapies
    SWOT Analysis
    DelveInsight Report Introduction
    Keytruda- Overview
    Product Description
    Route of Synthesis
    Mechanism of Action
    Adverse Reactions
    Regulatory Milestones by Region
    Deals and Partnerships
    Product Details
    Keytruda Sales Assessment
    Historical Sales
    Forecasted Sales
    Patent Details by Region
    Company Financials
    Market Competition
    Emerging Therapies*
    Drug 1
    Product Description
    Research and Development
    Product Development Activities
    SWOT Analysis
    Consulting Services
    About DelveInsight
    Contact Us
    Table 1: Keytruda, Description
    Table 2: Keytruda, Product Details
    Table 3: Keytruda, Historical Sales (in million USD)
    Table 4: Keytruda, Forecasted Sales from 2017-2019 (in million USD)
    Table 5: Keytruda, Patent Details
    Table 6: Company, Overview
    Table 7: Keytruda Major Competitors Keytruda
    Table 8: Emerging Therapies
    Figure 1: Keytruda, Historical Sales (in million USD)
    Figure 2: Keytruda, Forecasted Sales from 2017-2019 (in million USD)
    Merck & Co.
    Non-Small Cell Lung Cancer
    Head and Neck Squamous Cell Cancer

    Classical Hodgkin Lymphoma


    Urothelial Carcinoma
    Microsatellite Instability-High Cancer
    Keytruda Marketed Drugs Overview
    Keytruda Market Assessment
    Keytruda API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
    Keytruda US DMF
    Keytruda US Drug Master Files
    Keytruda Active Substance Master File/ EUDMF
    Keytruda Generic players
    Keytruda Patent Expiration
    Keytruda Patent Exclusivity
    Keytruda API Manufacturers
    Keytruda Global Forecasted Sales Figure
    Keytruda API Route of Synthesis
    Keytruda Market sales
    Keytruda SWOT Analysis
    Keytruda Pipeline
    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap